We spoke with Oliver Horn, CEO of Elixinol Global, on the company’s opportunities in over-the-counter CBD-based products in the cannabis space. And on the company’s recent acquisition in German, the liberal regulatory environment in which Elixinol operates and the current turnaround plan for the company.
